Literature DB >> 20966773

Deep repetitive transcranial magnetic stimulation associated with improved social functioning in a young woman with an autism spectrum disorder.

Peter G Enticott1, Hayley A Kennedy, Abraham Zangen, Paul B Fitzgerald.   

Abstract

OBJECTIVES: There are currently no biomedical treatments targeting the core symptoms of autism spectrum disorders (ASDs). Considering evidence for cortical dysfunction in ASD, repetitive transcranial magnetic stimulation (rTMS) has been discussed as a potential therapeutic technique.
METHODS: We describe the application of a new type of rTMS, deep rTMS, to the bilateral medial prefrontal cortex in a young woman with a high-functioning ASD. High-frequency rTMS was applied for 15 minutes each consecutive weekday for an 11-day period (9 treatments in total). Self-reported assessments were conducted before the first rTMS session, immediately after the last rTMS session, and 1-month after the last rTMS session.
RESULTS: Self-reported assessments revealed a number of improvements after deep rTMS. These were primarily in the domain of social relating and interpersonal understanding and were corroborated by family members.
CONCLUSIONS: Deep rTMS in ASD may serve to remediate aspects of cortical dysfunction (as standard rTMS seems to do in depression and schizophrenia) and provides a potential new avenue for the development of a biomedical treatment of impaired social relating in ASD.

Entities:  

Mesh:

Year:  2011        PMID: 20966773     DOI: 10.1097/YCT.0b013e3181f07948

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  17 in total

Review 1.  Use of transcranial magnetic stimulation in autism spectrum disorders.

Authors:  Lindsay M Oberman; Alexander Rotenberg; Alvaro Pascual-Leone
Journal:  J Autism Dev Disord       Date:  2015-02

2.  Coil design considerations for deep transcranial magnetic stimulation.

Authors:  Zhi-De Deng; Sarah H Lisanby; Angel V Peterchev
Journal:  Clin Neurophysiol       Date:  2013-12-22       Impact factor: 3.708

3.  Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs.

Authors:  Zhi-De Deng; Sarah H Lisanby; Angel V Peterchev
Journal:  Brain Stimul       Date:  2012-03-21       Impact factor: 8.955

Review 4.  Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research.

Authors:  Lindsay M Oberman; Peter G Enticott; Manuel F Casanova; Alexander Rotenberg; Alvaro Pascual-Leone; James T McCracken
Journal:  Autism Res       Date:  2015-11-04       Impact factor: 5.216

Review 5.  Changes in plasticity across the lifespan: cause of disease and target for intervention.

Authors:  Lindsay Oberman; Alvaro Pascual-Leone
Journal:  Prog Brain Res       Date:  2013       Impact factor: 2.453

Review 6.  Transcranial Magnetic Stimulation in Autism Spectrum Disorders: Neuropathological Underpinnings and Clinical Correlations.

Authors:  Manuel F Casanova; Estate M Sokhadze; Emily L Casanova; Xiaoli Li
Journal:  Semin Pediatr Neurol       Date:  2020-06-24       Impact factor: 1.636

7.  Modulating functional and dysfunctional mentalizing by transcranial magnetic stimulation.

Authors:  Tobias Schuwerk; Berthold Langguth; Monika Sommer
Journal:  Front Psychol       Date:  2014-11-18

Review 8.  Targeting Neural Endophenotypes of Eating Disorders with Non-invasive Brain Stimulation.

Authors:  Katharine A Dunlop; Blake Woodside; Jonathan Downar
Journal:  Front Neurosci       Date:  2016-02-16       Impact factor: 4.677

Review 9.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861

10.  'Drugs That Make You Feel Bad'? Remorse-Based Mitigation and Neurointerventions.

Authors:  Jonathan Pugh; Hannah Maslen
Journal:  Crim Law Philos       Date:  2015-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.